Predicting pediatric inflammatory bowel disease remission utilizing a clinical decision support tool

Key Points

• This research aims to evaluate the effectiveness of a clinical decision support tool (CDST) in predicting remission rates in children with inflammatory bowel disease.
• Utilized a clinical decision support tool to assess pediatric patients with inflammatory bowel disease.
• Analyzed the predictive capacity of the CDST for week 52 remission rates.
• Employed sensitivity analysis to determine cut points for remission prediction.
• The CDST showed significant applicability for predicting week 52 remission in pediatric patients.
• A CDST score greater than 19 demonstrated high sensitivity for predicting remission.